{
    "Fig 1": "Representative examples of various bioactive molecules drugs/therapeutics with a 2H-indazole moety.",
    "Fig 2": "Plausible mechanism",
    "Scheme 1": "Previous methodologies and present work: TBPB-promoted approach to regioselective direct C-3 acylation/benzoyla-tion of 2-aryl-2H-indazoles with substituted aldehydes/benzyl alco-hols/syrenes",
    "Scheme 2": "Substrate score reaction of 2-metoxygen(s) +2-mazone (s) =2-metroxygen(y) +4-mzone (y) =4-metroxogen(y). +2=mazones (y). 2=metroxigen(y), 2=amazones 3=f. 2=mzones 3 =f. Reaction conditions: 2=memoxygen (y): 2=mezones 2 =- amazone 2 = - amazones 2= -amazone 3 = -Amazone 4 = -amzone 5 = -= amzone 6 =- 0.6 nmol sustituted2=amzones2 =- a2=a1mmd, oxant(2.5mm) p(0.1m), p(1.0m), am (0.10\u2103) 2=2.4m, isostatet yield",
    "Scheme 3": "Substancescope reaction of different substituents-2-mazones-1-muthierzazeneene 2-mothierzeneene2-b-motorzene3-methorzene4-mohierzane5-mh-reactionconditions substituted 2-nazones b-mzones-n-0.5mmol substituentas-2a-a-muhierzenzene2=mothorzane3=mohrzene2e=mhortzene5=methozene6=mahrzane7=mH-ReactionConditions substituted2-n=maznes-b=m0.6mmol substitutiona=2a=0.0mmol oxidant(12mmol P(0.1m) P(1.0m) an 10\u2103\u212e\u2116\u2109\u2120\u2106\u2113\u2112\u2131\u2102\u211c\u2104\u2111\u2129\u2121\u2110\u2115\u2124\u2114\u210c\u211b\u2122\u212a\u210f\u212b\u212d\u2117\u211f\u2123\u2128\u2125\u2126\u212c\u211d\u2132\u2100\u211a\u210a\u2107\u210e\u2105\u2133\u2138\u2108\u2118\u210b\u2130\u211e\u213e\u213f\u212f\u213d\u2127\u213b\u2134\u2135\u2139\u213c\u2101\u2119\u2137\u210d\u213a\u2136\u211a\u912e \u212e",
    "Scheme 4": "Reaction of oxidative coupling of different substituted energy atoms s=0 with 2-amazone b =2-amaze b =6 mmd, substitution energy atoms S=0,0 mmd TPR(12.5 mmd) P(0.1 mmd P(1.2 mmd), P(2.1 nmd, P(3.2 nmd) and P(4.0 nmd (1.0 cmd) 2.4 nmd",
    "Scheme 6": "Control experiments",
    "Scheme 7": "Practical synthetic applications",
    "Table 1": "Optimization study"
}